Cenisertib benzoate - CAS 1145859-64-8

Cenisertib benzoate is an orally bioavailable, synthetic, small-molecule multi-Aurora kinase inhibitor with potential antineoplastic activity.

Others, Aurora Kinase, STAT, FLT, Akt, Bcr-Abl

Cell Cycle/Checkpoint, PI3K/Akt/mTOR signaling, Tyrosine Kinase/Adaptors, Others, Chromatin/Epigenetic, Cytoskeletal Signaling, Stem Cells, JAK/STAT signaling, Angiogenesis

1145787

C31H36FN7O3

573.66

C(O)(=O)C1=CC=CC=C1.N([C@@H]1[C@@]2(C[C@]([C@@H]1C(N)=O)(C=C2)[H])[H])C3=NC(NC4=CC(C)=C(C=C4)N5CCN(C)CC5)=NC=C3F

-20°C

Ice Packs

Small Compound